GlassScriptPhysician profile
Lisa Field
NPI 1841910783
$1,344.37
in general payments reported to CMS, 2019-2025
16 companies · $40.25 in 2025
The $40.25 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $224 · 2023: $947 · 2024: $134 · 2025: $40.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,045 · Education: $76.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,044.66 |
| Education | $76.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $389.43 | 2022-2024 | |
| Pfizer INC. | $175.21 | 2022-2023 | |
| Celgene Corporation | $150.60 | 2022-2023 | Zeposia |
| Genzyme Corporation | $116.97 | 2022-2023 | |
| Nestle Healthcare Nutrition INC. | $98.82 | 2022-2023 | |
| Intercept Pharmaceuticals, INC. | $92.61 | 2023 | Ocaliva |
| Janssen Biotech, INC. | $76.00 | 2023 | Stelara |
| Takeda Pharmaceuticals U.S.A., INC. | $55.21 | 2023 | Entyvio |
| E.R. Squibb & Sons, L.L.C. | $45.36 | 2024 | Sotyktu |
| Ipsen Biopharmaceuticals, INC | $29.03 | 2024 | Bylvay |
| Galderma Laboratories, L.P. | $21.97 | 2024 | |
| Heron Therapeutics, INC. | $21.78 | 2025 | Zynrelef |
| Daiichi Sankyo INC. | $20.36 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $18.86 | 2022 | |
| Smith+Nephew, INC. | $18.47 | 2025 | Pico |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aimmune Therapeutics, INC. | $13.69 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Field listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.